Can a drug stop lung spots from becoming cancer? new trial for smokers.
Prevention
Recruiting now
This study tests a drug called nadunolimab to see if it can shrink high-risk lung nodules in current or former heavy smokers. About 59 people will receive the drug and be followed for up to 5 years. The goal is to prevent these nodules from turning into lung cancer.
Phase: PHASE2 • Sponsor: Robert Samstein • Aim: Prevention
Last updated May 07, 2026 18:42 UTC